WENTZ MYRON W 4
4 · USANA HEALTH SCIENCES INC · Filed Jun 14, 2024
Insider Transaction Report
Form 4
WENTZ MYRON W
Director
Transactions
- Sale
Common Stock
2024-06-14$45.03/sh−13,496$607,725→ 7,864,345 total(indirect: Shares owned of record by Gull Global Limited) - Sale
Common Stock
2024-06-12$47.79/sh−2,202$105,234→ 7,877,841 total(indirect: Shares owned of record by Gull Global Limited)
Footnotes (3)
- [F1]Represents the weighted average price rounded to the nearest hundredths. Actual prices in multiple transactions ranged from $47.50 to $48.03, inclusive. The reporting persons undertake to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities Exchange Commission information regarding the number of shares sold at each price within the range set forth.
- [F2]Represents the weighted average price rounded to the nearest hundredths. Actual prices in multiple transactions ranged from $45.00 to $45.125, inclusive. The reporting persons undertake to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities Exchange Commission information regarding the number of shares sold at each price within the range set forth.
- [F3]The holder of record of the shares of Common Stock disposed of is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. Gull Global Limited is directly owned 50% by Viron Company Limited and 50% by Myogen Limited, each of which is a company formed under the Commonwealth of the Bahamas and is wholly indirectly owned and controlled by Dr. Wentz.